Limit CEA Application to Premium-Given Drugs with Big Sales: EFPIA Japan Officials

October 29, 2018
EFPIA Japan Pricing & Economics Committee Chairman Kuniyuki Hara (left), Access Committee Chair Yasuko Aitoku If Japan is to roll out a full-scale cost-effective assessment (CEA) scheme, it should be positioned as a supplemental tool for drug pricing and its...read more